Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.04 (+1.76%)
As of: Nov 11, 2026 · 3:59 PM EST

Artelo Biosciences (ARTL) Times Interest Earned (2017 - 2026)

Updated

Artelo Biosciences' Times Interest Earned was -26.89 in Q1 2026.

Analysis

Artelo Biosciences (ARTL) Times Interest Earned (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Artelo Biosciences' Times Interest Earned was -39.84 through Mar 31, 2026; for FY2025, it was -58.78.

  • In earlier years, Times Interest Earned was -2057.40 in FY2022.
  • The Q1 2026 figure marks the highest quarterly Times Interest Earned since Q2 2017.
  • Per Business Quant data, ARTL's Times Interest Earned in the three quarters before Q1 2026 was -253.27 (Q4 2025), -27.83 (Q3 2025) and -43.75 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 28.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.20
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 5.68
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.87
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Artelo Biosciences 49.32 Mn 32.53 Mn - -417.50
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -417.50
Mar 31, 2026 -26.89
Dec 31, 2025 -253.27
Sep 30, 2025 -27.83
Jun 30, 2025 -43.75
Sep 30, 2022 -478.80
Nov 30, 2019 -2.28
Aug 31, 2017 -652.84
May 31, 2017 -105.54
Feb 28, 2017 -11.81
API Access

Artelo Biosciences Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=ARTL&period=max&api_key=YOUR_API_KEY